Leaps by Bayer — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
65LAB accelerates drug discovery and therapeutic company formation by connecting academic research institutions, life science investors, and Evotec to develop novel medicines into commercial entities.
BiotechDeep TechSingapore, SG
BoardSteve Courtney(Expert in Residence)
Co-investorsLightstone VenturesClavystBio
Andes is a mission-driven company focused on protecting the planet and applying technology in a nature-related context.
AgTechBiotechClimate Tech
Co-investorsCapria VenturesCavallo VenturesGermin8 VenturesSunna VenturesVoyager PartnersYamaha Motor Ventures+1 more
Mozart Therapeutics develops protein therapeutics focused on immunology and oncology treatments.
BiotechMedical Devices
Mark Davis(Scientific Co-Founder)K. Christopher Garcia(Scientific Co-Founder)Calvin Kuo(Scientific Co-Founder)Katie Fanning(President & Chief Executive Officer)
Co-investorsARCH Venture PartnersJDRF T1D FundMRL Ventures FundOno Venture Investment, Inc.Pfizer Venture InvestmentsSofinnova Partners+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.